No abstract available
MeSH terms
-
Androgen Antagonists / therapeutic use
-
Biomarkers, Tumor / blood
-
Chemotherapy, Adjuvant
-
Disease Progression
-
Early Diagnosis
-
Humans
-
Male
-
Neoplasm Grading
-
Neoplasm Recurrence, Local / diagnosis
-
Neoplasm Recurrence, Local / pathology
-
Neoplasm Recurrence, Local / therapy
-
Neoplasm Staging
-
Prognosis
-
Prostate-Specific Antigen / blood
-
Prostatectomy
-
Prostatic Neoplasms / diagnosis
-
Prostatic Neoplasms / mortality
-
Prostatic Neoplasms / pathology*
-
Prostatic Neoplasms / therapy*
-
Radiotherapy Planning, Computer-Assisted
-
Radiotherapy, Intensity-Modulated
-
Seminal Vesicles / pathology
-
Seminal Vesicles / surgery
-
Survival Rate
Substances
-
Androgen Antagonists
-
Biomarkers, Tumor
-
Prostate-Specific Antigen